JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/22973

Title: Analysis of Patient Survival in a Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma
Authors: ALLEN B. J.
SINGLA A
RAJA C.
RIZVI S.
GRAHAM P.
BRUCHERTSEIFER Frank
APOSTOLIDIS Christos
MORGENSTERN Alfred
Citation: IMMUNOTHERAPY vol. 3 no. 9 p. 1041-1050
Publisher: FUTURE MEDICINE LTD
Publication Year: 2011
JRC Publication N°: JRC65533
ISSN: 1750-743X
URI: http://www.futuremedicine.com/doi/abs/10.2217/imt.11.97
http://publications.jrc.ec.europa.eu/repository/handle/111111111/22973
DOI: 10.2217/IMT.11.97
Type: Articles in Journals
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top